Study protocol, rationale and recruitment in a European multi-centre randomized controlled trial to determine the efficacy and safety of azithromycin maintenance therapy for 6 months in primary ciliary dyskinesia

Helene E. Kobbernagel; Frederik F. Buchvald; Eric G. Haarman; Carmen Casaulta; Samuel A. Collins; Claire Hogg; Claudia E. Kuehni; Jane S. Lucas; Heymut Omran; Alexandra L. Quittner; Claudius Werner; Kim G. Nielsen

doi:https://doi.org/10.1186/s12890-016-0261-x

Study protocol, rationale and recruitment in a European multi-centre randomized controlled trial to determine the efficacy and safety of azithromycin maintenance therapy for 6 months in primary ciliary dyskinesia

Helene E. Kobbernagel, Frederik F. Buchvald, Eric G. Haarman, Carmen Casaulta, Samuel A. Collins, Claire Hogg, Claudia E. Kuehni, Jane S. Lucas, Heymut Omran, Alexandra L. Quittner, Claudius Werner, Kim G. Nielsen

Research output: Contribution to journal › Article › Academic › peer-review

49 Citations (Scopus)

Original language	English
Article number	104
Journal	BMC Pulmonary Medicine
Volume	16
DOIs	https://doi.org/10.1186/s12890-016-0261-x
Publication status	Published - 22 Jul 2016

Keywords

Azithromycin
Exacerbation
Health-related quality of life
Lung clearance index
Multiple breath washout
Primary ciliary dyskinesia
QOL-PCD

Access to Document

https://doi.org/10.1186/s12890-016-0261-x

Cite this

Kobbernagel, H. E., Buchvald, F. F., Haarman, E. G., Casaulta, C., Collins, S. A., Hogg, C., Kuehni, C. E., Lucas, J. S., Omran, H., Quittner, A. L., Werner, C., & Nielsen, K. G. (2016). Study protocol, rationale and recruitment in a European multi-centre randomized controlled trial to determine the efficacy and safety of azithromycin maintenance therapy for 6 months in primary ciliary dyskinesia. BMC Pulmonary Medicine, 16, Article 104. https://doi.org/10.1186/s12890-016-0261-x

@article{03c5c8ed0be24c02bd07eda7c4df7af0,

title = "Study protocol, rationale and recruitment in a European multi-centre randomized controlled trial to determine the efficacy and safety of azithromycin maintenance therapy for 6 months in primary ciliary dyskinesia",

keywords = "Azithromycin, Exacerbation, Health-related quality of life, Lung clearance index, Multiple breath washout, Primary ciliary dyskinesia, QOL-PCD",

author = "Kobbernagel, {Helene E.} and Buchvald, {Frederik F.} and Haarman, {Eric G.} and Carmen Casaulta and Collins, {Samuel A.} and Claire Hogg and Kuehni, {Claudia E.} and Lucas, {Jane S.} and Heymut Omran and Quittner, {Alexandra L.} and Claudius Werner and Nielsen, {Kim G.}",

year = "2016",

month = jul,

day = "22",

doi = "https://doi.org/10.1186/s12890-016-0261-x",

language = "English",

volume = "16",

journal = "BMC Pulmonary Medicine",

issn = "1471-2466",

publisher = "BioMed Central",

}

Kobbernagel, HE, Buchvald, FF, Haarman, EG, Casaulta, C, Collins, SA, Hogg, C, Kuehni, CE, Lucas, JS, Omran, H, Quittner, AL, Werner, C & Nielsen, KG 2016, 'Study protocol, rationale and recruitment in a European multi-centre randomized controlled trial to determine the efficacy and safety of azithromycin maintenance therapy for 6 months in primary ciliary dyskinesia', BMC Pulmonary Medicine, vol. 16, 104. https://doi.org/10.1186/s12890-016-0261-x

Study protocol, rationale and recruitment in a European multi-centre randomized controlled trial to determine the efficacy and safety of azithromycin maintenance therapy for 6 months in primary ciliary dyskinesia. / Kobbernagel, Helene E.; Buchvald, Frederik F.; Haarman, Eric G. et al.
In: BMC Pulmonary Medicine, Vol. 16, 104, 22.07.2016.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Study protocol, rationale and recruitment in a European multi-centre randomized controlled trial to determine the efficacy and safety of azithromycin maintenance therapy for 6 months in primary ciliary dyskinesia

AU - Kobbernagel, Helene E.

AU - Buchvald, Frederik F.

AU - Haarman, Eric G.

AU - Casaulta, Carmen

AU - Collins, Samuel A.

AU - Hogg, Claire

AU - Kuehni, Claudia E.

AU - Lucas, Jane S.

AU - Omran, Heymut

AU - Quittner, Alexandra L.

AU - Werner, Claudius

AU - Nielsen, Kim G.

PY - 2016/7/22

Y1 - 2016/7/22

KW - Azithromycin

KW - Exacerbation

KW - Health-related quality of life

KW - Lung clearance index

KW - Multiple breath washout

KW - Primary ciliary dyskinesia

KW - QOL-PCD

U2 - https://doi.org/10.1186/s12890-016-0261-x

DO - https://doi.org/10.1186/s12890-016-0261-x

M3 - Article

C2 - 27450411

SN - 1471-2466

VL - 16

JO - BMC Pulmonary Medicine

JF - BMC Pulmonary Medicine

M1 - 104

ER -

Kobbernagel HE, Buchvald FF, Haarman EG, Casaulta C, Collins SA, Hogg C et al. Study protocol, rationale and recruitment in a European multi-centre randomized controlled trial to determine the efficacy and safety of azithromycin maintenance therapy for 6 months in primary ciliary dyskinesia. BMC Pulmonary Medicine. 2016 Jul 22;16:104. doi: https://doi.org/10.1186/s12890-016-0261-x